Since the level of EGFR was high in chemoresistant lung cancer, the EGFR-specific inhibitor gefitinib was administered to NCI-H460TXR and A549TXR cells to determine the sensitivity to gefitinib in paclitaxel-resistant lung cancer (Supplementary Figure S2C,D). This evidence concerns the gene EGFR and lung cancer.